Whipplewood Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Whipplewood Advisors's EW Position: Q2 2026 in Review
Whipplewood Advisors reduced its Edwards Lifesciences (EW) stake by 96% in Q2 2026, selling an estimated $18.3K and leaving 9 shares worth $814. The position accounts for ﹤0.01% of the portfolio, ranked #571.
Whipplewood Advisors first reported a position in EW in Q4 2024 and has held it in 5 quarters since. The position peaked at $18.3K in Q1 2026. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Whipplewood Advisors held 9 shares of Edwards Lifesciences worth $814 as of Q2 2026.
- Whipplewood Advisors sold 219 Edwards Lifesciences shares in Q2 2026, an estimated $18.3K.
- Edwards Lifesciences made up ﹤0.01% of Whipplewood Advisors's portfolio in Q2 2026, its #571 holding.
- Whipplewood Advisors first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 5 quarters since.
- Whipplewood Advisors's Edwards Lifesciences position peaked at $18.3K in Q1 2026.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.